SemBioSys Genetics Inc.

SemBioSys Genetics Inc. (SBS.TSX) is a biotechnology company engaged in the development and commercialization of protein pharmaceutical and non-pharmaceutical products. PlatformOur proprietary protein production system addresses major commercialization challenges associated with the production of recombinant proteins; overcoming limitations in scale, capital and production costs. SemBioSys’ proprietary technology harnesses the natural ability of seeds to produce, extract and purify proteins in large quantities and at low cost, while dramatically reducing downstream purification costs. It is unique as the only transgenic technology that addresses protein recovery and purification simultaneously with bulk protein production. SemBioSys’ technology is compatible with simple peptides, polypeptides and complex proteins such as antibodies.

Contact Details: 110, 2985 - 23rd Avenue Calgary Nebraska AB T1Y 7L3 United States of America Tel: 403.250.5424 Fax: 403.250.3886 Email: info@sembiosys.com WWW: www.sembiosys.com/

Loading...

Recent Publications by SemBioSys Genetics Inc.:
Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. The increased incidence of diabetes, coupled with the introduction of...	27th January, 2007	SemBioSys Genetics Inc, 110, 2985-23 Ave NE, Calgary, AB, T1Y 7L3, Canada.	Plant Biotechnol J. 2006 Jan;4(1):77-85. DOI Direct Link
Precise and efficient cleavage of recombinant fusion proteins using mammalian aspartic proteases. Expression of recombinant proteins as translational fusions is commonly...	3rd July, 2004	SemBioSys Genetics Inc., 110 2985 23rd Avenue NE, Calgary AB T1Y 7L3,	Protein Eng. 2003 Oct;16(10):777-83.

BioNews Results for SemBioSys Genetics Inc.:
Final Call to Register for BioPartnering Europe (BPE)	Reuters:  Oct 2 2008 9:37PM Matching: sembiosys genetics inc
Final Call to Register for BioPartnering Europe (BPE)	Business Wire via Yahoo!:  Oct 2 2008 9:29PM Matching: sembiosys genetics inc
SemBioSys eligible to proceed with Phase	Checkbiotech:  Sep 17 2008 11:52AM Matching: sembiosys genetics inc
SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND	Nashville Business Journal:  Sep 16 2008 1:25PM Matching: sembiosys genetics inc
SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND	Atlanta Business Chronicle:  Sep 16 2008 1:16PM Matching: sembiosys genetics inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more SemBioSys Genetics Inc. news.

SemBioSys Genetics Inc. Patents:
US Patent No.	Title
7390936	Commercial production of chymosin in plants
6372234	Products for topical applications comprising oil bodies
6288304	Expression of somatotropin in plant seeds
6210742	Uses of oil bodies
6183762	Oil body based personal care products
→View more SemBioSys Genetics Inc. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 186 times since April 2007, the link to the organisation's website has been followed 38 times

Recent Search Terms used to find this page: SemBioSys Genetics Inc.- caglary | www.sembiosys.com | protein companies in calgary | sembiosys | .

Search for more companies in Calgary

Search for more companies in Nebraska

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for SemBioSys Genetics Inc.